|
GW-1100
|
|
306974-70-9
|
|
PH-064
|
|
892546-37-1
|
|
ML216
|
|
1430213-30-1
|
|
Entasobulin
|
|
501921-61-5
|
|
Boc-Dap-NE
|
|
160800-65-7
|
|
Roblitinib (FGF401)
|
|
1708971-55-4
|
|
Orelabrutinib
|
|
1655504-04-3
|
|
ML-162
|
|
1035072-16-2
|
|
LEM-14
|
|
1814881-70-3
|
|
MSBN
|
|
135980-66-4
|
|
DL5H3
|
|
90263-34-6
|
|
Nicomol
|
|
27959-26-8
|
|
Dronedarone
|
|
141626-36-0
|
|
GRA Ex-25
|
|
307983-31-9
|
|
CCT241736
|
|
1402709-93-6
|
|
TIC10 (ONC201)
|
|
1616632-77-9
|
|
BI-847325
|
|
1207293-36-4
|
|
PF-05221304
|
|
1370448-25-1
|
|
SYP-5
|
|
1384268-04-5
|
|
Batefenterol
|
|
743461-65-6
|
|
FB23
|
|
2243736-35-6
|
|
Treosulfan
|
|
299-75-2
|
|
AZ 10606120 dihydrochloride
|
|
607378-18-7
|
|
PEO-IAA
|
|
6266-66-6
|
|
AEM1
|
|
1030123-90-0
|
|
ARN272
|
|
488793-85-7
|
|
GSK2200150A
|
|
1443138-53-1
|
|
TVB-3166
|
|
1533438-83-3
|
|
BAY-293
|
|
2244904-70-7
|
|
TH 5487
|
|
2304947-71-3
|
|
SKF38393 HCL
|
|
62717-42-4
|
|
PIM1/AKK1-IN-1
|
|
1093222-27-5
|
|
GLPG0634 analogue
|
|
1206101-20-3
|
|
BAR501
|
|
1632118-69-4
|
|
T 5601640
|
|
924473-59-6
|
|
imidazenil
|
|
151271-08-8
|
|
Ciforadenant (CPI-444)
|
|
1202402-40-1
|
|
LY2795050
|
|
1346133-08-1
|
|
GSK2981278
|
|
1474110-21-8
|
|
Elafibranor
|
|
923978-27-2
|
|
TM5007
|
|
342595-05-5
|
|
JNJ-63533054
|
|
1802326-66-4
|
|
FF-10101
|
|
1472797-69-5
|
|
Eliprodil
|
|
119431-25-3
|
|
TSPC
|
|
882286-32-0
|
|
MS4078
|
|
2229036-62-6
|
|
JTE-013
|
|
383150-41-2
|
|
TAK-632
|
|
1228591-30-7
|
|
AZD-5069
|
|
878385-84-3
|
|
Seltorexant
|
|
1293281-49-8
|
|
8-Bromo-cAMP sodium salt
|
|
76939-46-3
|
|
(-)-Dizocilpine
|
|
121917-57-5
|
|
NCGC 607
|
|
1462267-07-7
|
|
R243
|
|
688352-84-3
|
|
SKLB-23bb
|
|
1815580-06-3
|
|
GATA4-NKX2-5-IN-1
|
|
544681-96-1
|
|
Fmoc-3VVD-OH
|
|
863971-44-2
|
|
PD-089828
|
|
179343-17-0
|
|
AZD2098
|
|
566203-88-1
|
|
GSK-114
|
|
1301761-96-5
|
|
Mc-Val-Ala-PAB
|
|
1870916-87-2
|
|
NDI-091143
|
|
2375840-87-0
|
|
ML397
|
|
731006-86-3
|
|
VU6015929
|
|
2442597-56-8
|
|
GW9508
|
|
885101-89-3
|
|
Cinacalcethydrochloride
|
|
364782-34-3
|
|
Maraviroc
|
|
376348-65-1
|
|
AMD-070
|
|
558447-26-0
|
|
BQ-123 SODIUM SALT
|
|
136553-81-6
|
|
TAK-779
|
|
229005-80-5
|
|
GANT 61
|
|
500579-04-4
|
|
Vortioxetine(LuAA21004)HBr
|
|
960203-27-4
|
|
BNC105
|
|
945771-74-4
|
|
Fmoc-Phe-Lys(Trt)-PAB-PNP
|
|
1116086-09-9
|
|
Voxelotor (GBT440)
|
|
1446321-46-5
|
|
ARN14974
|
|
1644158-57-5
|
|
5WKS
|
|
1350752-07-6
|
|
CYM2503
|
|
1308833-36-4
|
|
PZ-2891
|
|
2170608-82-7
|
|
JNJ-7777120
|
|
459168-41-3
|
|
ML417
|
|
1386162-69-1
|
|
Simetride
|
|
154-82-5
|
|
Conivaptan hydrochloride
|
|
168626-94-6
|
|
OC000459
|
|
851723-84-7
|
|
BAY 57-1293
|
|
348086-71-5
|
|
Tazemetostat (EPZ-6438)
|
|
1403254-99-8
|
|
PF-3450074
|
|
1352879-65-2
|
|
Matrine
|
|
519-02-8
|
|
GSK2256098
|
|
1224887-10-8
|
|
LOUREIRIN B
|
|
119425-90-0
|
|
FDL-169
|
|
1628416-28-3
|
|
BAY 59-3074
|
|
406205-74-1
|
|
Maytansine
|
|
35846-53-8
|
|
VUF 10166
|
|
155584-74-0
|
|
TAE-1
|
|
1414469-59-2
|
|
LY2828360
|
|
1231220-79-3
|
|
MCHR1 antagonist 2
|
|
863115-70-2
|
|
UBCS039
|
|
358721-70-7
|
|
TH-257
|
|
2244678-29-1
|
|
WUN-29654
|
|
2407829-65-4
|